Yüklüyor......

The discovery and development of belimumab: the anti-BLyS–lupus connection

For the first time in more than 50 years, the US Food and Drug Administration has approved a drug specifically for the treatment of systemic lupus erythematosus (SLE). This drug, belimumab (Benlysta), is a human monoclonal antibody that neutralizes the B-cell survival factor, B-lymphocyte stimulator...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Stohl, William, Hilbert, David M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3264947/
https://ncbi.nlm.nih.gov/pubmed/22231104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.2076
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!